FULC
Fulcrum Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$7.65
+0.02 ▲ +0.26%
🌙 3월 13일 4:10 PM ET (한국 3/14 05:10)
$7.65
+0.00 +0.00%
| Index | RUT | P/E | - | EPS (ttm) | -1.18 | Insider Own | 14.85% | Shs Outstand | 0.07B | Perf Week | -6.36% |
| Market Cap | 0.51B | Forward P/E | - | EPS next Y | -22.91% | Insider Trans | -29.93% | Shs Float | 0.06B | Perf Month | -29.62% |
| Enterprise Value | 0.16B | PEG | - | EPS next Q | -0.29 | Inst Own | 88% | Short Float | 7.43% | Perf Quarter | -44.57% |
| Income | -0.07B | P/S | - | EPS this Y | -7.85% | Inst Trans | 27.53% | Short Ratio | 4.48 | Perf Half Y | 9.44% |
| Sales | 0.00B | P/B | 1.46 | EPS next 5Y | 2.55% | ROA | -23.89% | Short Interest | 4.21M | Perf YTD | -32.36% |
| Book/sh | 5.24 | P/C | 1.45 | EPS past 3/5Y | 21.49% 15.8% | ROE | -25.3% | 52W High | -51.4% ($15.74) | Perf Year | 163.79% |
| Cash/sh | 5.29 | P/FCF | - | Sales past 3/5Y | - | ROIC | -21.21% | 52W Low | 230.45% ($2.32) | Perf 3Y | 70% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -498.13% | Gross Margin | - | Volatility(W/M) | 6.09% 8.08% | Perf 5Y | -37.4% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | -100% | Oper. Margin | - | ATR (14) | 0.69 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 27.4 | EPS Q/Q | -0.65% | Profit Margin | - | RSI (14) | 33.23 | Recom | 1.5 |
| Dividend Gr. 3/5Y | - | Current Ratio | 27.4 | Sales Q/Q | - | SMA20 | -14.95% ($8.99) | Beta | 3.3 | Target Price | $19 |
| Payout | - | Debt/Eq | 0.02 | Earnings | 2000000 | SMA50 | -22.42% ($9.86) | Rel Volume | 0.57 | Prev Close | $7.63 |
| Employees | 55 | LT Debt/Eq | 0.01 | EPS/Sales Surpr. | -3.64% - | SMA200 | -12.88% ($8.78) | Avg Volume(3M) | 0.94M | Price | $7.65 |
| IPO | 2019/7/18 | Option/Short | Yes/Yes | Trades | 6796 | Volume | 536,827 | Change | 0.26% |
뉴스 로딩 중...